Two Trials looking at Inhibitors in 1st-line Therapy Combinations, Cediranib & Olapanib, and Bevacizumab & Olapanib - 102191

Spotlight
Video

Two Trials looking at Inhibitors in 1st-line Therapy Combinations, Cediranib & Olapanib, and Bevacizumab & Olapanib

Cancer-News has 158 videos Subscribe Here

Loading........
Description: Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, discusses Two Trials looking at Inhibitors in 1st-line Therapy Combinations, Cediranib & Olapanib, and Bevacizumab & Olapanib.
Shared By : Cancer-News
Posted on : 04/10/18
Added : 8 months ago
Category : Ovarian Cancer



Recommended

Nothing found.